Product Quick Detail

FOB Price
USD $100.00 / Piece
Minimum Order
10
Place Of Origin
China
Packaging
N/A
Delivery
15 Days

It inhibits both circulating and clot-bound thrombin, while also inhibiting thrombin-mediated platelet activation and aggregation. Bivalirudin is indicated for use as an anticoagulant in patients with unstable angina undergoing percutaneous transluminal coronary angioplasty (PTCA).
Bivalirudin with provisional use of glycoprotein IIb/IIIa (GPI) is indicated for use as an anticoagulant in patients undergoing percutaneous coronary intervention (PCI).
  • Country: China (Mainland)
  • Business Type: Shenzhen JYMedtech Co,Ltd.
  • Founded Year: 2009
  • Address: Rm.2-408, Shenzhen Bio-incubator Base, 10 Gaoxin C. 1st, Nanshan District, Shenzhen, GD, China, 518057
  • Contact: Camille Wu

Shenzhen JYMedtech Co,Ltd.

Enter between 20 to 3,000 characters. English only. Characters: 0 / 3000
submiting now We do inquire for you, please wait...